Senior insider sale
EVP, CRO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$28.38M
60.46K shares
What this filing means
SACHDEV AMIT plans to sell 60.46K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $28.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/25/2026ACC: 0001959173-26-001460
Officer· EVP, CRO
Since Jun 2018
60.46K
Shares to sell
$28.38M
Approx. market value
1.85K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/24/2026
1.85KTotal acquired1.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 1.85K | — |
| Total | 1.85K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
58.61K
Market value
$27.48M
2/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.85K
Market value
$897.8K
2/25/2026
Total
Units
60.46K
Value
$28.38M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/19/2026 | 58.61K | $27.48M | — | Completed |
| Planned — Approximate Date | ||||
2/25/2026 | 1.85K | $897.8K | NASDAQ | Planned |
| Total | 60.46K | $28.38M | ||